Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock

$19.68

0.76% day before yesterday

NYSE, Sep 06, 10:10 pm CET

ISIN

US3580291066

Symbol

FMS

Reports

Quarter | Annual

Index

CDAX, NYSE Composite

Sector

Health

Industry

Health service provider

Overview Dividends Analysts Charts News Strategies

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock price

$19.68

-14.58 42.56% 5Y

NYSE, Closing price Fri, Sep 06 2024

-0.15 0.76%

ISIN

US3580291066

Symbol

FMS

Reports

Quarter | Annual

Index

CDAX, NYSE Composite

Sector

Health

Industry

Health service provider

Key metrics

Market capitalization	$11.55b
Enterprise Value	$24.32b
P/E (TTM) P/E ratio	20.18
EV/FCF (TTM) EV/FCF	16.51
EV/Sales (TTM) EV/Sales	1.16
P/S ratio (TTM) P/S ratio	0.55
P/B ratio (TTM) P/B ratio	0.77
Dividend yield	3.27%
Last dividend (FY24)	$0.64
Revenue growth (TTM) Revenue growth	2.27%
Revenue (TTM) Revenue	$20.99b
EBIT (operating result TTM) EBIT	$1.88b
Free Cash Flow (TTM) Free Cash Flow	$1.47b
Cash position	$1.17b
EPS (TTM) EPS	$0.98
P/E forward	16.60
P/S forward	0.55
EV/Sales forward	1.16
Short interest	0.20%

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Get Started for Free Today

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock Analysis

Unlock Scores for Free

??

19 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

6x Buy

32%

7x Hold

37%

6x Sell

32%

More details on Analyst Estimates Including Price Targets

19 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

Buy

32%

Hold

37%

Sell

32%

Analyst Estimates with Stock Price Targets

Financial data from Fresenius Medical Care AG & Co. KGaA Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '24		+/- %
Revenue	20,993 20,993	2% 2% 100%
- Direct Costs	15,675 15,675	3% 3% 75%
Gross Profit	5,318 5,318	1% 1% 25%
- Selling and Administrative Expenses	1,520 1,520	9% 9% 7%
- Research and Development Expense	230 230	7% 7% 1%
EBITDA	3,569 3,569	6% 6% 17%
- Depreciation and Amortization	1,694 1,694	12% 12% 8%
EBIT (Operating Income) EBIT	1,875 1,875	30% 30% 9%
Net Profit	572 572	8% 8% 3%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock News

Neutral

PRNewsWire

●

3 days ago

Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Fresenius Medical Care achieves growth milestone of more than 14,000 U.S.-based patients using the Company's NxStage systems to perform Home Hemodialysis therapy This growth has generated greater adoption from a range of dialysis providers and delivers on the company's commitment to grow access to and use of home dialysis therapy The newest NxStage® Versi®HD with GuideMe Software home dialysis ...

Neutral

Seeking Alpha

●

about one month ago

Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript

Fresenius Medical Care AG (NYSE:FMS ) Q2 2024 Earnings Call July 30, 2024 8:00 AM ET Company Participants Dominik Heger - Head, Investor Relations Helen Giza - Chief Executive Officer and Chair Martin Fischer - Chief Financial Officer Conference Call Participants Veronika Dubajova - Citi Richard Felton - Goldman Sachs Graham Doyle - UBS Hassan Al-Wakeel - Barclays Victoria Lambert - Berenberg H...

Neutral

PRNewsWire

●

about one month ago

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

Organic revenue growth of +2.3% supported by both segments Care Delivery and Care Enablement Operating income1 and operating income margin1 increase driven by Care Enablement Additional FME25 savings of EUR 57 million achieved and on track to reach the upper end of the full year savings target range Further divestitures closed as execution of portfolio optimization program continues Net financi...

More Fresenius Medical Care AG & Co. KGaA Sponsored ADR News

Company Profile

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Head office	Germany
CEO	Helen Giza
Employees	119,845
Founded	1996
Website	www.freseniusmedicalcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now